Cerity Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.7M Sell
440,706
-6,181
-1% -$476K 0.04% 331
2025
Q4
$35.5M Sell
446,887
-89,609
-17% -$7.06M 0.05% 289
2025
Q3
$40.4M Buy
536,496
+104,401
+24% +$7.15M 0.07% 241
2025
Q2
$29.8M Sell
432,095
-216,171
-33% -$14.2M 0.05% 283
2025
Q1
$43.9M Buy
648,266
+129,535
+25% +$7.75M 0.09% 202
2024
Q4
$24M Sell
518,731
-99,249
-16% -$5.57M 0.05% 281
2024
Q3
$38.9M Sell
617,980
-107,360
-15% -$6.26M 0.09% 206
2024
Q2
$42.8M Sell
725,340
-348,061
-32% -$21.8M 0.11% 166
2024
Q1
$85.6M Buy
1,073,401
+123,706
+13% +$9.45M 0.23% 97
2023
Q4
$75M Buy
949,695
+181,516
+24% +$12.9M 0.25% 96
2023
Q3
$53.6M Sell
768,179
-361,282
-32% -$25.6M 0.26% 101
2023
Q2
$78.1M Buy
1,129,461
+215,657
+24% +$15.3M 0.3% 76
2023
Q1
$95.1M Sell
913,804
-157,035
-15% -$13.2M 0.22% 63
2022
Q4
$99.8M Buy
1,070,839
+267,762
+33% +$25.8M 0.64% 30
2022
Q3
$76.6M Buy
803,077
+35,153
+5% +$3.48M 0.92% 16
2022
Q2
$71.2M Buy
767,924
+352,883
+85% +$34.4M 0.79% 16
2022
Q1
$42M Sell
415,041
-347,180
-46% -$36.5M 0.65% 30
2021
Q4
$78.6M Buy
762,221
+593,347
+351% +$54.8M 1.2% 11
2021
Q3
$14.3M Buy
168,874
+22,310
+15% +$1.87M 0.32% 67
2021
Q2
$12.2M Buy
146,564
+1,854
+1% +$152K 0.27% 77
2021
Q1
$10.9M Sell
144,710
-12,591
-8% -$917K 0.26% 84
2020
Q4
$10.7M Buy
157,301
+27,403
+21% +$1.78M 0.34% 61
2020
Q3
$7.58M Buy
129,898
+46,368
+56% +$2.89M 0.31% 67
2020
Q2
$5.42M Buy
83,530
+460
+0.6% +$29K 0.3% 67
2020
Q1
$4.93M Buy
83,070
+6,967
+9% +$465K 0.31% 65
2019
Q4
$5.65M Sell
76,103
-25,582
-25% -$1.8M 0.29% 73
2019
Q3
$6.41M Sell
101,685
-4,414
-4% -$262K 0.38% 63
2019
Q2
$5.78M Buy
106,099
+41,526
+64% +$2.24M 0.36% 68
2019
Q1
$3.48M Buy
64,573
+11,646
+22% +$719K 0.23% 90
2018
Q4
$3.47M Sell
52,927
-2,517
-5% -$188K 0.23% 100
2018
Q3
$4.37M Sell
55,444
-13,283
-19% -$950K 0.3% 83
2018
Q2
$4.42M Buy
68,727
+3,521
+5% +$232K 0.33% 72
2018
Q1
$4.06M Sell
65,206
-4,403
-6% -$316K 0.31% 80
2017
Q4
$5.05M Sell
69,609
-8,939
-11% -$650K 0.34% 63
2017
Q3
$6.39M Buy
78,548
+75,924
+2,893% +$6.01M 0.45% 40
2017
Q2
$246K Sell
2,624
-71,028
-96% -$5.61M 0.02% 315
2017
Q1
$5.78M Buy
73,652
+50,845
+223% +$4.06M 0.48% 33
2016
Q4
$1.8M Buy
+22,807
New +$1.85M 2.48% 16

Other funds holding CVS

Cerity Partners's CVS Position: Q1 2026 in Review

Cerity Partners reduced its CVS Health (CVS) stake by 1.4% in Q1 2026, selling an estimated $476K and leaving 440,706 shares worth $31.7M. The position accounts for 0.04% of the portfolio, ranked #331.

Cerity Partners first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $99.8M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Cerity Partners held 440,706 shares of CVS Health worth $31.7M as of Q1 2026.
  • Cerity Partners sold 6,181 CVS Health shares in Q1 2026, an estimated $476K.
  • CVS Health made up 0.04% of Cerity Partners's portfolio in Q1 2026, its #331 holding.
  • Cerity Partners first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
  • Cerity Partners's CVS Health position peaked at $99.8M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.